During late tumorigenesis, heterogeneous cancer-associated fibroblasts (CAFs) were identified in mouse models of breast cancer, including a population of CD34– myofibroblastic CAFs (myCAFs) that were transcriptionally and phenotypically similar to senescent CAFs. This evidence concerns the gene CD34 and breast cancer.